Cargando…

ET-13 CONTROL OF ACTIVATED MICROGLIA THROUGH P2X4 RECEPTOR IN RADIATION BRAIN NECROSIS

INTRODUCTION: Brain radiation necrosis (RN) is severe adverse event after radiation therapy for brain tumor patients, especially in case of re-irradiation. Although corticosteroids or vitamin E, etc. are clinically used for RN, the effect is limited and underlying mechanism is to be cleared. Therefo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Natsuko, Kondo, Yoshinori, Sakurai, Kajihara, Takayuki, Takada, Takushi, Takai, Nobuhiko, Kume, Kyo, Miyatake, Shinichi, Oda, Shoji, Suzuki, Minoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213195/ http://dx.doi.org/10.1093/noajnl/vdz039.043

Ejemplares similares

Persistent elevation of lysophosphatidylcholine promotes radiation brain necrosis with microglial recruitment by P2RX4 activation
por: Kondo, Natsuko, et al.
Publicado: (2022)

A case of radiation-induced osteosarcoma treated effectively by boron neutron capture therapy
por: Futamura, Gen, et al.
Publicado: (2014)

Effect of Tirapazamine, Metformin or Mild Hyperthermia on Recovery From Radiation-Induced Damage in Pimonidazole-Unlabeled Quiescent Tumor Cells
por: Masunaga, Shin-ichiro, et al.
Publicado: (2017)

ACT-3 Reactor-based boron neutron capture therapy with add-on bevacizumab for recurrent malignant glioma: The final report
por: Furuse, Motomasa, et al.
Publicado: (2021)

Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up
por: Takai, Satoshi, et al.
Publicado: (2021)

Tumour necrosis factor-alpha induces an increase in susceptibility of human glioblastoma U87-MG cells to natural killer cell-mediated lysis.
por: Kondo, S., et al.
Publicado: (1994)

Glioma Stem-Like Cells Can Be Targeted in Boron Neutron Capture Therapy with Boronophenylalanine
por: Kondo, Natsuko, et al.
Publicado: (2020)

10031-RT-02 Results of reactor-based BNCT for 44 cases of recurrent and refractory high-grade meningiomas and road to accelerator based BNCT
por: Miyatake, Shin-Ichi, et al.
Publicado: (2020)

Intensity-modulated irradiation for superficial tumors by overlapping irradiation fields using intensity modulators in accelerator-based BNCT
por: Sasaki, Akinori, et al.
Publicado: (2022)

Development of optimization method for uniform dose distribution on superficial tumor in an accelerator-based boron neutron capture therapy system
por: Sasaki, Akinori, et al.
Publicado: (2023)

Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell population
por: Masunaga, Shin-ichiro, et al.
Publicado: (2013)

Radiosensitivity and Capacity to Recover from Radiation-Induced Damage in Pimonidazole-Unlabeled Intratumor Quiescent Cells Depend on p53 Status
por: Masunaga, Shin-ichiro, et al.
Publicado: (2011)

Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas – A Pilot Study
por: SHIBA, Hiroyuki, et al.
Publicado: (2018)

Boron Neutron Capture Therapy for Malignant Brain Tumors
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2016)

Usefulness of Daily Fractionated Administration of Wortmannin Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis
por: Masunaga, Shin-ichiro, et al.
Publicado: (2013)

An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed (10)B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness
por: Masunaga, Shin-ichiro, et al.
Publicado: (2020)

The impact of TP53 status of tumor cells including the type and the concentration of administered (10)B delivery agents on compound biological effectiveness in boron neutron capture therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2023)

HER-2-targeted boron neutron capture therapy using an antibody-conjugated boron nitride nanotube/β-1,3-glucan complex
por: Yamana, Keita, et al.
Publicado: (2023)

ET-4 BASIC RESEARCH OF BORON NEUTRON CAPTURE THERAPY USING A NOVEL BORON COMPOUND TARGETED TO INTEGRIN
por: Tsujino, Kohei, et al.
Publicado: (2022)

Subcapital Fracture with Avascular Necrosis of the Whole Femoral Head After Fixation of an Intertrochanteric Fracture: A Case Report
por: Fukuoka, Natsuko, et al.
Publicado: (2020)

Epithelioid glioblastoma with microglia features: potential for novel therapy
por: Nakagomi, Nami, et al.
Publicado: (2020)

Effect of bevacizumab combined with boron neutron capture therapy on local tumor response and lung metastasis
por: MASUNAGA, SHIN-ICHIRO, et al.
Publicado: (2014)

The dependency of compound biological effectiveness factors on the type and the concentration of administered neutron capture agents in boron neutron capture therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2014)

Evaluating the Usefulness of a Novel (10)B-Carrier Conjugated With Cyclic RGD Peptide in Boron Neutron Capture Therapy
por: Masunaga, Shin-ichiro, et al.
Publicado: (2012)

Long-term changes of spine dynamics and microglia after transient peripheral immune response triggered by LPS in vivo
por: Kondo, Satoru, et al.
Publicado: (2011)

BK channels in microglia are required for morphine-induced hyperalgesia
por: Hayashi, Yoshinori, et al.
Publicado: (2016)

Microdosimetric quantities of an accelerator-based neutron source used for boron neutron capture therapy measured using a gas-filled proportional counter
por: Hu, Naonori, et al.
Publicado: (2020)

Pro- and anti-epileptic roles of microglia
por: Kinoshita, Shinichi, et al.
Publicado: (2020)

Pathophysiology, Diagnosis, and Treatment of Radiation Necrosis in the Brain
por: MIYATAKE, Shin-Ichi, et al.
Publicado: (2015)

ACT-02 BORON NEUTRONS CAPTURE THERAPY FOR RECURRENT HIGH-GRADE MENINGIOMAS, FROM REACTOR TO ACCELERATOR
por: Miyatake, Shin-Ichi, et al.
Publicado: (2019)

Interleukin 13 on Microglia is Neurotoxic in Lipopolysaccharide-injected Striatum in vivo
por: Hong, Ah Reum, et al.
Publicado: (2022)

Carborane-Containing Hydroxamate MMP Ligands for the Treatment of Tumors Using Boron Neutron Capture Therapy (BNCT): Efficacy without Tumor Cell Entry
por: Flieger, Sebastian, et al.
Publicado: (2023)

Abscopal Activation of Microglia in Embryonic Fish Brain Following Targeted Irradiation with Heavy-Ion Microbeam
por: Yasuda, Takako, et al.
Publicado: (2017)

Significance of Fractionated Administration of Thalidomide Combined With γ-Ray Irradiation in Terms of Local Tumor Response and Lung Metastasis
por: Masunaga, Shin-ichiro, et al.
Publicado: (2014)

Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain
por: Konno, Shinichi, et al.
Publicado: (2016)

Embryonic Medaka Model of Microglia in the Developing CNS Allowing In Vivo Analysis of Their Spatiotemporal Recruitment in Response to Irradiation
por: Yasuda, Takako, et al.
Publicado: (2015)

Caspase blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia
por: Kim, S J, et al.
Publicado: (2013)

Reverse Signaling of Tumor Necrosis Factor Superfamily Proteins in Macrophages and Microglia: Superfamily Portrait in the Neuroimmune Interface
por: Lee, Won-Ha, et al.
Publicado: (2019)

NI-04 Evaluation of post boron neutron capture therapy for recurrent meningioma using fluoride-labeled boronophenylalanine PET
por: Takai, Satoshi, et al.
Publicado: (2020)

Neuroprotection and Disease Modification by Astrocytes and Microglia in Parkinson Disease
por: Takahashi, Shinichi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1gfse5e0gto6n22hjgj6ptjc7o